Cargando…
Corticosteroids for Patients With Coronavirus Disease 2019 (COVID-19) With Different Disease Severity: A Meta-Analysis of Randomized Clinical Trials
OBJECTIVES: Efficacy and safety of corticosteroids in patients with 2019-nCoV (novel coronavirus 2019) infection still are debated. Because large randomized clinical trials (RCTs) and a well-conducted meta-analysis on the use of corticosteroids, focused on patients with coronavirus disease (COVID-19...
Autores principales: | Pasin, Laura, Navalesi, Paolo, Zangrillo, Alberto, Kuzovlev, Artem, Likhvantsev, Valery, Hajjar, Ludhmila Abrahão, Fresilli, Stefano, Lacerda, Marcus Vinicius Guimaraes, Landoni, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698829/ https://www.ncbi.nlm.nih.gov/pubmed/33298370 http://dx.doi.org/10.1053/j.jvca.2020.11.057 |
Ejemplares similares
-
Efficacy and safety of IL-6 inhibitors in patients with COVID-19 pneumonia: a systematic review and meta-analysis of multicentre, randomized trials
por: Belletti, Alessandro, et al.
Publicado: (2021) -
Effects of COVID-19 pandemic on out-of-hospital cardiac arrests: A systematic review
por: Scquizzato, Tommaso, et al.
Publicado: (2020) -
Anakinra for patients with COVID-19: a meta-analysis of non-randomized cohort studies.
por: Pasin, Laura, et al.
Publicado: (2021) -
Nations with high smoking rate have low SARS-CoV-2 infection and low COVID-19 mortality rate
por: Landoni, Giovanni, et al.
Publicado: (2020) -
MicroCLOTS pathophysiology in coronavirus disease 2019
por: Renzi, Samuele, et al.
Publicado: (2023)